(Q38321172)

2 September 2017

1 reference

title

The global impact of non-communicable diseases on healthcare spending and national income: a systematic review (English)

1 reference

2 September 2017

1 reference

9

1 reference

2 September 2017

Raha Pazoki

11

0 references

Sven J van der Lee

object named as

Sven J van der Lee

series ordinal

6

0 references

Oscar H Franco

object named as

Oscar H Franco

series ordinal

12

0 references

Rajiv Chowdhury

series ordinal

8

object named as

Rajiv Chowdhury

1 reference

2 September 2017

1

Taulant Muka

1 reference

2 September 2017

3

Loes Jaspers

1 reference

2 September 2017

5

Layal Chaker

1 reference

2 September 2017

10

Abby Falla

1 reference

2 September 2017

7

Shanthi Mendis

1 reference

2 September 2017

4

Veronica Colpani

1 reference

2 September 2017

David Imo

2

1 reference

2 September 2017

18 January 2015

1 reference

European Journal of Epidemiology

2 September 2017

1 reference

2 September 2017

30

1 reference

2 September 2017

4

1 reference

2 September 2017

251-277

1 reference

https://scigraph.springernature.com/pub.10.1007/s10654-014-9984-2

2 September 2017

0 references

cites work

Inequalities in non-communicable diseases and effective responses

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Resource use in the last 6 months of life among medicare beneficiaries with heart failure, 2000-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Care needs and economic consequences after acute ischemic stroke: the Erlangen Stroke Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Outcomes and Excess Costs among Patients with Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Readmission, mortality, and first-year medical costs after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Cost analysis of lung cancer management in South Western Sydney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Present and future costs of COPD in Iceland and Norway: results from the BOLD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Effect of chronic kidney disease and comorbid conditions on health care costs: A 10-year observational study in a general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Clinical outcomes, quality of life, and costs in the North Thames Dialysis Study of elderly people on dialysis: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Prevalence of multiple chronic conditions in the United States' Medicare population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

The cost of health conditions in a health maintenance organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Excessive costs of COPD in ever-smokers. A longitudinal community study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

The economic burden of type 2 diabetes mellitus in rural southwest China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

The cost of first-ever stroke in Valle d'Aosta, Italy: linking clinical registries and administrative data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Incidence-based cost-of-illness model for metastatic breast cancer in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Social and economic costs and health-related quality of life in stroke survivors in the Canary Islands, Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Indirect costs associated with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Cost impact of COPD in Japan: opportunities and challenges?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

The costs of breast cancer prior to and following diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Economic burden of osteoporosis, breast cancer, and cardiovascular disease among postmenopausal women in an employed population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Evaluation of trends in the cost of initial cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Cost of illness of adult diabetes mellitus underestimated if comorbidity is not considered.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Growth in medicare expenditures for patients with acute myocardial infarction: a comparison of 1998 through 1999 and 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Cost trends among commercially insured and Medicare Advantage-insured patients with chronic obstructive pulmonary disease: 2006 through 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

The direct medical cost of diabetes in Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Resource utilization and costs of stroke unit care integrated in a care continuum: A 1-year controlled, prospective, randomized study in elderly patients: the Göteborg 70+ Stroke Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Costs of COPD in Sweden according to disease severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Pharmacoeconomic evaluation of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Acute care costs of patients admitted for management of chronic obstructive pulmonary disease exacerbations: contribution of disease severity, infection and chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Costs of chronic bronchitis and COPD: a 1-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

The financial costs of healthcare treatment for people with Type 1 or Type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Clinical and economic burden of patients diagnosed with COPD with comorbid cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Economic burden of cardiovascular diseases in the enlarged European Union

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Direct health care costs of diabetic patients in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Revealing the cost of Type II diabetes in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Medical care expenditures for selected circulatory diseases: opportunities for reducing national health expenditures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

The impact of the aging population on coronary heart disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Lifetime cost of stroke subtypes in Australia: findings from the North East Melbourne Stroke Incidence Study (NEMESIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

The disease burden of colorectal cancer in Hungary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

The Direct Medical Costs of Colorectal Cancer in Iran; Analyzing the Patient's Level Data from a Cancer Specific Hospital in Isfahan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Burden of hospital admissions for cervical cancer in Spain during 1999-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Cost of care for elderly cancer patients in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Economic costs of diabetes in the US in 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Increasing hospital admission rates and economic burden for colorectal cancer in Brazil, 1996-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Recent trends in Veterans Affairs chronic condition spending

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Cost of stroke in Australia from a societal perspective: results from the North East Melbourne Stroke Incidence Study (NEMESIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Productivity loss resulting from coronary heart disease in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

COPD in the working age population: the economic impact on both patients and government

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Economic costs of diabetes in the U.S. In 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Lifetime cost of stroke in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Productivity savings from colorectal cancer prevention and control strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Economic studies in colorectal cancer: challenges in measuring and comparing costs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Socioeconomic variation in the financial consequences of ill health for older people with chronic diseases: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Costs, outcomes and challenges for diabetes care in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Cardiovascular diseases and diabetes as economic and developmental challenges in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

A review of the costs and cost effectiveness of interventions in chronic kidney disease: implications for policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

The impact of diabetes mellitus on healthcare costs in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Costs of stroke using patient-level data: a critical review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

The costs of treating breast cancer in the US: a synthesis of published evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

The economic impact of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

'More than just money' -- widening the understanding of the costs involved in cancer care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

The costs of diabetes and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

The costs of cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Healthcare utilization and costs among chronic bronchitis patients treated with maintenance medications from a US managed care population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Economic cost associated with type II diabetes in Spanish patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Changes in COPD demographics and costs over 20 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Metastatic breast cancer: we do need primary cost data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Cost disparities in lung cancer treatment by disability status, sex, and race

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Economics of the clinical management of lung cancer in France: an analysis using a Markov model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Burden of new hospitalization for heart failure: a population-based investigation from Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Health care costs for treatment of disseminated breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Glycemic control and diabetes-related health care costs in type 2 diabetes; retrospective analysis based on clinical and administrative databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Care of acute myocardial infarction by noninvasive and invasive cardiologists: procedure use, cost and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Direct costs for care and glycaemic control in patients with type 2 diabetes in Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Hospital costs incurred by the Italian National Health Service for invasive cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Estimating the lifetime economic burden of stroke according to the age of onset in South Korea: a cost of illness study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Structure and costs of health care of diabetic patients in Finland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Direct medical costs for patients with type 2 diabetes and related complications: a prospective cohort study based on the Korean National Diabetes Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry: the Erlangen Stroke Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

The impact of a new payment system with case-mix measurement on hospital practices for breast cancer patients in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Economic burden associated with breast cancer recurrence: findings from a retrospective analysis of health system data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Medical costs of fourteen occupational illnesses in the United States in 1999

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Vulnerability, beliefs, treatments and economic burden of chronic obstructive pulmonary disease in rural areas in China: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Patterns of care in early-stage breast cancer survivors in the first year after cessation of active treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Assessing the costs of chronic obstructive pulmonary disease: the state medicaid perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Direct medical costs of COPD--an excess cost approach based on two population-based studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Major complications have an impact on total annual medical cost of diabetes: results of a database analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Medical expenditure for diabetic patients: a 10-year follow-up study of National Health Insurance in Shiga, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Cancer-attributable costs of diagnosis and care for persons with screen-detected versus symptom-detected colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Cost of illness associated with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Treatment costs of acute myocardial infarction in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Costs of stroke care according to handicap levels and stroke subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Variations in hospitalisation costs for acute myocardial infarction - a comparison across Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

The economic burden of chronic cardiovascular disease for major insurers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Long-term disease-related costs 4 years after stroke or TIA in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Differences among the elderly in the treatment costs of colorectal cancer: how important is race?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Lifetime direct medical costs of treating type 2 diabetes and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Costs and rehabilitation use of stroke survivors: a retrospective study of Medicare beneficiaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-014-9984-2

Lifetime and treatment-phase costs associated with colorectal cancer: evidence from SEER-Medicare data

21 January 2018

1 reference

12 December 2020

Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis.

1 reference

12 December 2020

Cost of breast cancer treatment. A 4-year longitudinal study

1 reference

12 December 2020

Epidemiology of complications and total treatment costs from diagnosis of Type 2 diabetes in Germany (ROSSO 4)

1 reference

12 December 2020

Direct costs to primary care of chronic bronchitis. Analysis of a prospective study

1 reference

12 December 2020

The time course of subsequent hospitalizations and associated costs in survivors of an ischemic stroke in Canada

1 reference

12 December 2020

[Costs of coronary heart diseases over the remaining life time in coronary heart disease cases--an analysis of the current status of coronary heart disease cases in Germany from the social perspective]

1 reference

12 December 2020

Evaluation of the cost of stroke management in Dakar, Senegal

1 reference

12 December 2020

The burden of diabetes mellitus for medicare beneficiaries

1 reference

12 December 2020

The association between diabetes related medical costs and glycemic control: a retrospective analysis.

1 reference

12 December 2020

Cost of care for cancer in a health maintenance organization

1 reference

12 December 2020

Research gap in cardiovascular disease in developing countries

1 reference

12 December 2020

The costs of cardiorespiratory disease episodes in a study of emergency department use

1 reference

12 December 2020

Cost of illness in patients with metastatic colorectal cancer

1 reference

12 December 2020

Cost of care of colorectal cancers according to health care patterns and stage at diagnosis in France

1 reference

12 December 2020

Estimation of the prevalence, incidence, comorbidities and direct costs associated to stroke patients requiring care in an area of the Spanish population

1 reference

12 December 2020

1 reference

12 December 2020

Ischemic stroke and intracerebral hemorrhage: the latest evidence on mortality, readmissions and hospital costs from Scotland

1 reference

12 December 2020

[Assessment of diabetes mellitus type 2 treatment costs in the Republic of Serbia]

1 reference

12 December 2020

Breast cancer attributable costs in Germany: a top-down approach based on sickness funds data

1 reference

12 December 2020

Estimating the lifelong health impact and financial burdens of different types of lung cancer

1 reference

12 December 2020

Estimation of hospital costs for colorectal cancer care in Nova Scotia

1 reference

12 December 2020

Colon cancer treatment costs for Medicare and dually eligible beneficiaries.

1 reference

12 December 2020

Screening and the costs of treating colorectal cancer: some preliminary results

1 reference

12 December 2020

Cost of diagnostic and therapeutic management of colorectal cancer according to stage at diagnosis in the Calvados Département, France

1 reference

12 December 2020

Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association

1 reference

12 December 2020

Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective

1 reference

12 December 2020

Burden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs population

1 reference

12 December 2020

Cost analysis of an integrated care model in the management of acute exacerbations of chronic obstructive pulmonary disease

1 reference

12 December 2020

Chronic obstructive pulmonary disease involves substantial health-care service and social benefit costs.

1 reference

12 December 2020

Costs of management of patients with coronary artery disease in Poland: the multicenter RECENT study

1 reference

12 December 2020

Burden of disease associated with cervical cancer in malaysia and potential costs and consequences of HPV vaccination

1 reference

12 December 2020

[Cost of colorectal cancer in France in 1999]

1 reference

12 December 2020

One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database

1 reference

12 December 2020

Impact of disability status on ischemic stroke costs in Canada in the first year.

1 reference

12 December 2020

A retrospective analysis of disability and its related costs among employees with chronic obstructive pulmonary disease

1 reference

12 December 2020

Direct and indirect economic and health consequences of COPD in Denmark: a national register-based study: 1998-2010.

1 reference

12 December 2020

Direct cost of ambulatory care of type 2 diabetes in the middle and high income group populace of Delhi: the DEDICOM survey.

1 reference

12 December 2020

Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population

1 reference

12 December 2020

Medical care costs among patients with established cardiovascular disease.

1 reference

12 December 2020

Shifting the burden of health care finance: a case study of public-private partnership in Singapore

1 reference

12 December 2020

Direct medical costs attributable to acute myocardial infarction and ischemic stroke in cohorts with atherosclerotic conditions

1 reference

12 December 2020

A population-based analysis of health behaviours, chronic diseases and associated costs.

1 reference

12 December 2020

Comparison of approaches for estimating incidence costs of care for colorectal cancer patients

1 reference

12 December 2020

Estimating the treatment costs of breast and lung cancer

1 reference

12 December 2020

Clinical and economic burden of COPD in a medicaid population

1 reference

12 December 2020

Hospital costs of colorectal cancer care

1 reference

12 December 2020

Health and economic burden of HPV-related diseases in Singapore

1 reference

12 December 2020

Medical costs associated with use of systemic therapy in adults with colorectal cancer

1 reference

12 December 2020

Costs and survival of patients with colorectal cancer in a health maintenance organization and a preferred provider organization

1 reference

12 December 2020

Economic burden of diabetes mellitus in the WHO African region

1 reference

12 December 2020

Direct medical cost of stroke: findings from a tertiary hospital in malaysia

1 reference

12 December 2020

Marginal costing methods highlight the contributing cost of comorbid conditions in Medicare patients: a quasi-experimental case-control study of ischemic stroke costs.

1 reference

12 December 2020

The consequences and costs of chronic kidney disease before ESRD

1 reference

12 December 2020

[Effectiveness and efficiency of a specialized unit in the care of patients with chronic obstructive pulmonary disease and respiratory insufficiency]

1 reference

12 December 2020

10.1007/S10654-014-9984-2

Identifiers

DOI

1 reference

PubMed ID

25595318

Dimensions Publication ID

2 September 2017

0 references

1 reference

PubMed ID

25595318